ArticleActa neuropathologica2022

Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention.

Pablo Botella Lucena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.